In the development from Low to High-grade glioma, CCNB2 enhanced SASP cytokines production and the deterioration of tumor microenvironment, which significantly accelerated cell malignant transformation and progression of glioma (Figure 10). The gene discussed is CCNB2; the disease is central nervous system cancer.